Global Contrast Media Market Report 2024-2029 - Global Contrast Media Market to Reach $9.5 Billion by 2029, Driven by Geriatric Population and Chronic Disease Imaging
June 05, 2024 12:00 ET
|
Research and Markets
Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Global Contrast Media Market: Analysis By Type, By Indication, By Route of Administration, By Procedure, By End User, By Region Size, Trends and...
$2.2 Billion Barium Sulfate Markets - Global Industry Trends and Growth Analysis to 2030
April 23, 2024 10:13 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Barium Sulfate Market: Market Size, Trends and Growth Analysis [2024-2030]" report has been added to ResearchAndMarkets.com's offering.The global...
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Completed Production of a Test Batch of its SmoothX™ Barium Sulfate CT Contrast Media Oral Suspension for the Canadian CT Imaging Market
November 29, 2022 06:00 ET
|
InvestmentPitch Media and Voyageur Pharmaceutical
VANCOUVER, British Columbia, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals (TSXV:VM) (OTCPink:VYYRF) has completed production of a test batch of its SmoothX™ barium sulfate CT contrast...
Voyageur Restructures its ImagingX Joint Venture
March 20, 2020 08:00 ET
|
Voyageur Pharmaceuticals Ltd.
CALGARY, Alberta, March 20, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (the “Company” or “Voyageur”) is pleased to announce the dissolution of the current joint venture with...
Voyageur Pharmaceuticals Implements Frances Creek Environmental Strategy for Bulk Sample and Future Quarry Production
February 18, 2020 07:00 ET
|
Voyageur Pharmaceuticals Ltd.
CALGARY, Alberta, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSXV:VM) (the "Company" or "Voyageur") is implementing steps to ensure the Frances Creek barium sulfate project...
Voyageur Pharmaceuticals Confirms Frances Creek Barite Meets all Pharmaceutical Grade Specification
February 03, 2020 07:00 ET
|
Voyageur Pharmaceuticals Ltd.
CALGARY, Alberta, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSXV:VM) (the "Company" or "Voyageur") is pleased to announce successful test results by SGS Minerals & SGS...